Bruce is a partner in the intellectual property group at Smith, Gambrell & Russell, LLP, a 1979 graduate of the American University, Washington College of Law, and a member of the District of Columbia Bar. His firm has approximately 400 lawyers in 14 offices with headquarters in Atlanta, Georgia, and a national footprint in the field of intellectual property and biotechnology. His specialty is in trademark law and intellectual property litigation, but he has worked with innovative drug developers in the negotiation of licensing agreements, and in 2018 produced a series of published advocacy reports for the Pharmaceutical Research and Manufacturers Association (PhARMA) on the topic of compulsory licensing of pharmaceutical patents under international law.